To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06844383
Title A Study of Talazoparib with or Without Enzalutamide in People with Prostate Cancer Who Have Previously Received Abiraterone Acetate (TALENT)
Acronym TALENT
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Prostate Cancer Clinical Trials Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA